Steven Cohen’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-168,901
Closed -$4.67M – 4351
2026
Q2
$5.72M Buy
+168,901
New +$5.57M 0.01% 1665

Other funds holding NAMS

Steven Cohen's NAMS Position: Q3 2026 in Review

Steven Cohen sold out of NewAmsterdam Pharma (NAMS) in Q3 2026, closing a stake of 168,901 shares — an estimated $4.67M sold.

Steven Cohen first reported a position in NAMS in Q2 2026 and held it in 1 quarter. The position peaked at $5.72M in Q2 2026. 183 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.

  • Steven Cohen reported no remaining NewAmsterdam Pharma position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 168,901 NewAmsterdam Pharma shares in Q3 2026, an estimated $4.67M.
  • Steven Cohen first reported a position in NewAmsterdam Pharma in Q2 2026 and held it in 1 quarter.
  • Steven Cohen's NewAmsterdam Pharma position peaked at $5.72M in Q2 2026.
  • 183 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.